APA

Templin A. T., Mellati M., Soininen R., Hogan M. F., Esser N., Castillo J. J., Zraika S., Kahn S. E. & Hull R. L. (20200427). Loss of perlecan heparan sulfate glycosaminoglycans lowers body weight and decreases islet amyloid deposition in human islet amyloid polypeptide transgenic mice. : Protein engineering, design & selection : PEDS.

Chicago

Templin Andrew T, Mellati Mahnaz, Soininen Raija, Hogan Meghan F, Esser Nathalie, Castillo J Josh, Zraika Sakeneh, Kahn Steven E and Hull Rebecca L. 20200427. Loss of perlecan heparan sulfate glycosaminoglycans lowers body weight and decreases islet amyloid deposition in human islet amyloid polypeptide transgenic mice. : Protein engineering, design & selection : PEDS.

Harvard

Templin A. T., Mellati M., Soininen R., Hogan M. F., Esser N., Castillo J. J., Zraika S., Kahn S. E. and Hull R. L. (20200427). Loss of perlecan heparan sulfate glycosaminoglycans lowers body weight and decreases islet amyloid deposition in human islet amyloid polypeptide transgenic mice. : Protein engineering, design & selection : PEDS.

MLA

Templin Andrew T, Mellati Mahnaz, Soininen Raija, Hogan Meghan F, Esser Nathalie, Castillo J Josh, Zraika Sakeneh, Kahn Steven E and Hull Rebecca L. Loss of perlecan heparan sulfate glycosaminoglycans lowers body weight and decreases islet amyloid deposition in human islet amyloid polypeptide transgenic mice. : Protein engineering, design & selection : PEDS. 20200427.